Market Research Report
Anal Fistula Treatment - Global Market Outlook (2017-2026)
|Published by||Stratistics Market Research Consulting||Product code||662830|
|Published||Content info||138 Pages
Delivery time: 2-3 business days
|Anal Fistula Treatment - Global Market Outlook (2017-2026)|
|Published: June 1, 2018||Content info: 138 Pages||
According to Stratistics MRC, the Global Anal Fistula Treatment Market is accounted for $549.80 million in 2017 and expected to grow at a CAGR of 4.2% to reach $798.71 million by 2026. The increase in prevalence of inflammatory bowel diseases is triggering the market growth. However, the high cost associated with the treatments such as cost of surgery & the post-operative treatments and the lack of awareness regarding the condition are hindering the market. The non-surgical procedures for the treatment of anal fistula provide ample opportunities to the market.
By application, Extrasphincteric is a type or condition in the anal fistula. It begins at the rectum or sigmoid colon and proceeds downward, through the levator ani muscle and open into the skin surrounding the anus and this type does not arise from the dentate line. Causes of this type could be from a rectal, pelvic or supralevator origin, usually secondary to crohns disease or an inflammatory process such as appendiceal or divertical abscesses.
Based on treatment type, surgical methods for an anal fistula may lead to recurrence or impairment of continence. The perfect treatment for an anal fistula should be associated with low recurrence rates, minimal incontinence and good quality of life. The best option will depend on the position of fistula and whether it's a single channel or branches off in different directions. The most common type of surgery for anal fistulas is a fistulotomy.
By geography, emerging nations such as China, India, and countries in Southeast Asia are likely to add to the growth of the market in Asia Pacific. Initiatives to progress health care infrastructure, growing health care expenditures and trend of medical tourism in these countries are projected to boost the market in Asia Pacific. Moreover, the rise in number of cases are expected to rise in developing countries as compared to developed countries owing to western dietary patterns, increase in use of antibiotics, surge in exposure to pollution, and improvement in hygiene.
Some of the key players in the Anal Fistula market are Medtronic plc, Gem srl, biolitec AG, W. L. Gore & Associates, Inc. (Gore Medical), Becton, Dickinson and Company, TiGenix NV, KARL STORZ SE & Co. KG, Cook Medical, Novartis, Johnson & Johnson, Bristol Myers and Mylan.
Treatment Types Covered
End Users Covered:
What our report offers: